Revaxis, suspension injectable
7680006460041
CH-646
Injektionssuspension
Associated product:
REVAXIS susp inj av 1 aiguille 10 ser pré 0.5 ml
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionssuspension
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
29.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
7.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
26.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.35 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
12.5 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
2.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.12 MG | Substance | HBESI |
|
(N/A)
|
1.6 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 646
- Drug name
- Revaxis, suspension injectable
- Galenic form
- SUPA
- ATC Code
- J07CA01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 10/08/2000
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- REVAXIS susp inj av 1 aiguille 10 ser pré 0.5 ml
- Description (DE)
- REVAXIS Inj Susp mit 1 Nadel 10 Fertspr 0.5 ml
- Market launch
- 10/08/2000
- Narcotic (BTM)
- No
Application methods
SUBC
IMU